申请人:Gross Jonathan Laird
公开号:US20090023707A1
公开(公告)日:2009-01-22
The present invention provides a compound of formula I:
and the use thereof for the treatment of a central nervous system disorder related to or affected by the histamine-3 receptor.
本发明提供了一种化合物,其
化学式为I,并且提供了其用于治疗与
组胺-3受体相关或受其影响的中枢神经系统疾病的用途。